Healthcare - Biotechnology - NASDAQ - US
$ 5.29
-5.54 %
$ 307 M
Market Cap
-3.98
P/E
Price Target
Average
155.20%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
14.87%
Net Income
Estimate
30.57%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Rezolute, Inc.
Wall Street analysts predict an average 1-year price target for RZLT of $13.5 , with forecasts ranging from a low of $11 to a high of $15 .
RZLT Lowest Price Target
Wall Street Target
11 USD
107.94%
RZLT Average Price Target
Wall Street Target
13.5 USD
155.20%
RZLT Highest Price Target
Wall Street Target
15 USD
183.55%
REVENUE FORECAST
Revenue Forecast Chart RZLT
EBIT FORECAST
EBIT Forecast Chart RZLT
NET INCOME FORECAST
Net Income Chart RZLT